propentofylline
Sign in to savePropentofylline (HWA 285) is a xanthine derivative drug with purported neuroprotective effects.
Research
297 papers- Propentofylline for dementia.The Cochrane database of systematic reviews · 2003
- Propentofylline: glial modulation, neuroprotection, and alleviation of chronic pain.Handbook of experimental pharmacology · 2011
- Propentofylline, a CNS glial modulator does not decrease pain in post-herpetic neuralgia patients: in vitro evidence for differential responses in human and rodent microglia and macrophages.Experimental neurology · 2012
- Propentofylline in the treatment of Alzheimer's disease and vascular dementia: a review of phase III trials.Dementia and geriatric cognitive disorders · 1998
- Clinical trials in dementia with propentofylline.Annals of the New York Academy of Sciences · 1997
via PubMed
Wikidata facts
- Mass
- 306.169
Show 2 more facts
- chemical formula
- C₁₅H₂₂N₄O₃
- canonical SMILES
- CCCN1C=NC2=C1C(=O)N(C(=O)N2C)CCCCC(=O)C
Sources (2)
via Wikidata · CC0
~1 min read
Article
5 sectionsContents
- Pharmacology
- Uses
- See also
- External links
- References
Propentofylline (HWA 285) is a xanthine derivative drug with purported neuroprotective effects.
==Pharmacology== It is a phosphodiesterase inhibitor, and also acts as an adenosine reuptake inhibitor.
Available in 6 languages
via Wikidata sitelinks · CC0
Connections
adenosine receptor
Entity
dyphylline
Entity
diquafosol
Entity
8-cyclopentyl-1,3-dipropylxanthine
Entity
copper
Entity
calcium
Entity
zinc
Entity
magnesium
Entity
enzyme
Entity
Alzheimer's disease
Entity
stroke
Entity
ethanol
Entity
digital object identifier
Entity
chemical formula
Entity
caffeine
Entity
nucleotide
Entity
adenosine triphosphate
Entity
sildenafil
Entity
adenine
Entity
molar mass
Entity